::jseblod::article::/jseblod::
::panel_article:: ::/panel_article::
::wysiwyg_introtext::
AIMS: To determine the accuracy of the forced expiratory volume ratio at one and six seconds (FEV1/FEV6) using a hand-held, expiratory flow meter (PiKo-6®, nSpire Health, Inc.) to screen for chronic obstructive pulmonary disease (COPD) in primary care settings.
METHODS: Current and former smokers (> 50 years old) with no previous respiratory diagnosis (case finding [CF] = 204 subjects) or with an asthma diagnosis (differential diagnosis [DD] = 93 subjects) were evaluated using validated questionnaires, pre-bronchodilator (BD) FEV1/FEV6 and post-BD FEV1/forced vital capacity (FVC) spirometry.
RESULTS: The PiKo-6® FEV1/FEV6 showed good sensitivity and specificity (areas under the Receiver Operating Characteristic curves [95% confidence intervals]: CF = 0.85 [0.79, 0.90]; DD = 0.88 [0.80, 0.96]) and exceeded the accuracy of the questionnaires. An FEV1/FEV6 cutoff < 0.75 provided optimal sensitivity (CF = 81%; DD = 86%) and specificity (CF = 71%; DD = 67%) for COPD screening.
CONCLUSIONS: The PiKo-6® allows simple and reliable screening for COPD which could optimise early referral for spirometry and early, targeted interventions for COPD.
::/wysiwyg_introtext::::my_readmore:: ::/my_readmore::
::wysiwyg_fulltext::
Prim Care Respir J. 2011 May 20;
Authors: Frith P, Crockett A, Beilby J, Marshall D, Attewell R, Ratnanesan A, Gavagna G
Read Full Article
::panel_article_details:: ::/panel_article_details::
::panel_article_params:: ::/panel_article_params::
::panel_article_meta:: ::/panel_article_meta::
::panel_end:: ::/panel_end::
::jseblodend::::/jseblodend::
